Intra-action review (IAR)

Conducting an IAR during a emergency or a humanitarian crisis is crucial for facilitating real-time course correction, fostering immediate, and sustained learning and improvement within the response systems, allowing countries to continually assess and adapt their strategies. This country-led process enables stakeholders to evaluate the functional capacities of public health and emergency response systems at national or subnational levels during a health emergency or a humanitarian crisis. The aim is to identify best practices, challenges, lessons learned, and propose real-time corrective measures for immediate action or sustained improvement in the outbreak response.

 

 

Key Publication

IAR LOGO

Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR)

The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID-19 outbreak in their countries. The IAR is a country-led facilitated process conducted during the COVID-19 outbreak in-country, bringing together a small group of COVID-19 responders with knowledge of the public health response pillars under review. Although IARs can be conducted online or face-to-face, the online format is recommended, especially if community transmission remains high in the country. The IAR will identify practical areas for immediate remediation and sustained improvement of the ongoing response.

23 July 2026

Seven strategies to prevent drowning: technical package for policy-makers

22 July 2026

Consolidated HIV guidelines: service delivery

21 July 2026

Establishing a national programme for guideline adaptation: key steps and functions

21 July 2026

WHO Global Traditional Medicine Centre: Annual Report 2025

20 July 2026

Formative evaluation of the Global Health Cluster: Web annexes

20 July 2026

WHO Drug Information - Volume 40, No. 2

19 July 2026

Target product profile – developing in vitro diagnostics for low- and middle-income settings

17 July 2026

Eleventh Meeting of the WHO South-East Asia Regional Verification Commission for Measles and Rubella Elimination

15 July 2026

Risk reduction of cognitive decline and dementia: WHO guidelines, second edition

15 July 2026

Root cause analysis of low yellow fever vaccination coverage: user manual and questionnaire

14 July 2026

WHO target product profile for Bundibugyo virus disease vaccines, 14 July 2026

14 July 2026

Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women

13 July 2026

The Diagnostic testing for Ebola disease and Marburg virus disease: interim guidance, 9 July 2026

10 July 2026

Disarmament, demobilization and reintegration and mental health and psychosocial support: operational guidance

9 July 2026

WHO Expert Committee on Biological Standardization: eighty-first report

9 July 2026

Integrated approach to management of skin-related neglected tropical diseases and common skin conditions

8 July 2026

Global status report on cancer 2026: the future we choose together

8 July 2026

WHO optimal antiretroviral dosing guidance: recommendations for dosing medicines for HIV prevention and treatment in paediatric populations

8 July 2026

Ending the neglect to attain the sustainable development goals: noma control: technical brief

6 July 2026

Target product profile for formulations of hydroxyurea for the management of sickle cell disease in children

COVID-19 IAR Online Training

Global Analysis of COVID-19 IARs

WHO Press Conference

Overview: The Country COVID-19 Intra-Action Review (IAR) is a facilitated process that brings together COVID-19 responders from multiple sectors for experience sharing and collective learning, and it has been modelled after the WHO After Action Review (AAR) methodology. This course provides a general introduction to the management and the facilitation of an IAR during the ongoing COVID-19 pandemic through presentations, quizzes and an assessment at the end of the course to test the knowledge acquired. It targets any individuals or entities involved in the preparedness of and response to the COVID-19 outbreak at the national or subnational levels, including but not limited to Government officials, WHO staff, public health professionals, communities and partners.

In line with the advice and temporary recommendations from the 4th, 5th, 11th and 12th IHR (2005) Emergency Committee on COVID-19, a global analysis of IAR reports received by WHO in collaboration with all six WHO regional offices and country offices has been conducted. A total of 83 reports from 57 countries comprising 2556 best practices, 2366 challenges, and 2859 recommendations were analyzed and triangulated with 27 interviews and 29 survey consultations with countries. This global analysis took a solution-oriented angle aimed at consolidating and showcasing the various strategies adopted by countries to address and overcome common challenges to the COVID-19 response, and to bring these learning to the rest of the world to encourage peer learning. 

COVID-19 vaccination IAR

As countries conduct mini COVID-19 vaccine Post-Introduction Evaluation (mini-cPIE), also called the COVID-19 Vaccination Intra-Action Review (IAR), to review and adjust their COVID-19 vaccine roll-out, WHO will be hosting regular clinics for countries to share learnings with peer countries.